tert-Butyl 4-(2-chloro-4-(methoxycarbonyl)phenyl)piperazine-1-carboxylate, 95.0%, 1g

5-(di-tert-Butylphosphino)-1',3',5'-triphenyl-1'H-1,4'-bipyrazole, 98%, 5g

Gal alpha(1-3) core 6-Fucosylated N-Glycan 2AB (500pmol/vial)>98.0%(HPLC)1vial

5-Bromo-2-methyl-1-benzothiophene, 98%, 500mg

5-Amino-2-hydroxybenzoic acid, 97.00%, 1kg

(1S)-7′-[[Bis(1-methylethyl)amino]carbonyl]-2,2′,3,3′-tetrahydro-1,1′-spirobi[1H-indene]-7-carboxylic acid, 100mg

2-Fluoro-3-(trifluoromethyl)anisole, 95.0%, 1g

1-(5-bromopyrimidin-2-yl)ethan-1-amine hydrochloride, 95%, 5g

6-Iodo-[1,2,4]triazolo[4,3-a]pyridine, 98%, 5g

N-(2-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PROPANE-1-SULFONAMIDE, 95%, 1g

1,2,2,6,6-Pentamethylpiperidin-4-ol, 98.0%, 500g

4-(4-Bromophenyl)morpholine>98.0%(GC)(T)25g

4-Pentyloxyphenylboronic Acid (contains varying amounts of Anhydride)1g